Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 2,113 | 2,386 | 1,523 | 1,514 | 1,491 |
| Gross Profit | 2,113 | 2,386 | 1,523 | 1,514 | 1,491 |
| Operating Expenses | 17,789 | 18,799 | 16,740 | 14,655 | 14,526 |
| Operating Income | -15,676 | -16,413 | -15,217 | -13,141 | -13,035 |
| Interest Expense | 772 | 797 | 1,074 | 1,099 | 1,041 |
| Other Income | 67 | 168 | -2,464 | 153 | 215 |
| Pre-tax Income | -16,381 | -17,042 | -18,755 | -14,087 | -13,861 |
| Net Income Continuous | -16,381 | -17,042 | -18,755 | -14,087 | -13,861 |
| Net Income | $-16,381 | $-17,042 | $-18,755 | $-14,087 | $-13,861 |
| EPS Basic Total Ops | -0.21 | -0.23 | -0.27 | -0.25 | -0.25 |
| EPS Basic Continuous Ops | -0.18 | -0.20 | -0.24 | -0.20 | -0.20 |
| EPS Diluted Total Ops | -0.21 | -0.23 | -0.27 | -0.25 | -0.25 |
| EPS Diluted Continuous Ops | -0.18 | -0.20 | -0.24 | -0.20 | -0.20 |
| EBITDA(a) | $-15,233 | $-15,926 | $-14,727 | $-12,640 | $-12,535 |